EHMT2-mediated transcriptional reprogramming drives neuroendocrine transformation in non-small cell lung cancer.
Yang C, Ma S, Zhang J, Han Y, Wan L, Zhou W, Dong X, Yang W, Chen Y, Gao L, Cui W, Jia L, Yang J, Wu C, Wang Q, Wang L.
Yang C, et al. Among authors: zhou w.
Proc Natl Acad Sci U S A. 2024 Jun 4;121(23):e2317790121. doi: 10.1073/pnas.2317790121. Epub 2024 May 30.
Proc Natl Acad Sci U S A. 2024.
PMID: 38814866